HRTX(Heron Therapeutics, Inc.) · 财务报表

HRTX(Heron Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$86.35M$107.67M$127.04M$144.28M$154.90M
毛利润$40.33M$52.80M$61.94M$105.64M$113.56M
营业利润−$217.83M−$174.66M−$110.61M−$11.53M−$2.54M
净利润−$220.68M−$182.02M−$110.56M−$13.58M−$20.20M
经营现金流−$203.35M−$146.91M−$58.79M−$22.53M−$27.59M
自由现金流−$206.38M−$148.74M−$60.33M−$24.23M−$27.91M
摊薄每股收益$-2.24$-1.67$-0.80$-0.09$-0.12

Heron Therapeutics, Inc. HRTX